Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Beth K. Neilsen, Danielle E. Frodyma, Robert E. Lewis & Kurt W. Fisher. (2017) KSR as a therapeutic target for Ras-dependent cancers. Expert Opinion on Therapeutic Targets 21:5, pages 499-509.
Read now
Read now
Articles from other publishers (12)
Talina Mohapatra & Manjusha Dixit. (2022) IQ Motif Containing GTPase Activating Proteins (IQGAPs), A-Kinase Anchoring Proteins (AKAPs) and Kinase Suppressor of Ras Proteins (KSRs) in Scaffolding Oncogenic Pathways and Their Therapeutic Potential. ACS Omega 7:50, pages 45837-45848.
Crossref
Crossref
Manuel Jurado, Óscar Castaño & Antonio Zorzano. (2021) Stochastic modulation evidences a transitory EGF-Ras-ERK MAPK activity induced by PRMT5. Computers in Biology and Medicine 133, pages 104339.
Crossref
Crossref
Hyuk Moon & Simon Weonsang Ro. (2021) Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma. Journal of Liver Cancer 21:1, pages 1-11.
Crossref
Crossref
Nayana Devang, Adyashree Pani & G.K. Rajanikant. 2021. Protein Kinases in Drug Discovery. Protein Kinases in Drug Discovery
121
185
.
Elizabeth A. Germino, Joseph P. Miller, Lauri Diehl, Carter J. Swanson, Steffen Durinck, Zora Modrusan, Jeffrey H. Miner & Andrey S. Shaw. (2018) Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer. PLOS ONE 13:3, pages e0194998.
Crossref
Crossref
Danielle Frodyma, Beth Neilsen, Diane Costanzo-Garvey, Kurt Fisher & Robert Lewis. (2017) Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras. F1000Research 6, pages 1621.
Crossref
Crossref
L Benhaim, W Zhang, T Wakatsuki, D Yang, A Gerger, P Bohanes, D Paez, F Loupakis, M J LaBonte, Y Ning, R El-Khoueiry, R Ladner, P Wilson, H Zhang, G Giamas, J Stebbing & H J Lenz. (2014) Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer. The Pharmacogenomics Journal 15:3, pages 235-240.
Crossref
Crossref
Hua Zhang, Nicos Angelopoulos, Yichen Xu, Arnhild Grothey, Joao Nunes, Justin Stebbing & Georgios Giamas. (2015) Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer. Breast Cancer Research and Treatment 151:3, pages 555-568.
Crossref
Crossref
J Stebbing, H Zhang, Y Xu, L C Lit, A R Green, A Grothey, Y Lombardo, M Periyasamy, K Blighe, W Zhang, J A Shaw, I O Ellis, H J Lenz & G Giamas. (2014) KSR1 regulates BRCA1 degradation and inhibits breast cancer growth. Oncogene 34:16, pages 2103-2114.
Crossref
Crossref
Hua Zhang, Andrew Photiou, Arnhild Grothey, Justin Stebbing & Georgios Giamas. (2012) The role of pseudokinases in cancer. Cellular Signalling 24:6, pages 1173-1184.
Crossref
Crossref
Hussein Echrish, Leigh A. Madden, John Greenman & Anthony Maraveyas. (2011) The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis. Cancers 3:1, pages 267-284.
Crossref
Crossref
Joanne L. Yu, Rosie Xing, Chloe Milsom & Janusz Rak. (2010) Modulation of the oncogene-dependent tissue factor expression by kinase suppressor of ras 1. Thrombosis Research 126:1, pages e6-e10.
Crossref
Crossref